• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Integra Lifesciences (NQ: IART )

    28.69 -0.13 (-0.45%)
    Streaming Delayed Price Updated: 1:05 PM EDT, Jun 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 336,583
    Open 28.71
    Bid (Size) 28.67 (3)
    Ask (Size) 28.69 (3)
    Prev. Close 28.82
    Today's Range 28.11 - 28.71
    52wk Range 22.36 - 46.75
    Shares Outstanding 84,579,542
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    INTEGRA LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Integra LifeSciences Holdings Corporation - IART
    From Kahn Swick & Foti, LLC
    Via Business Wire
    NASDAQ:IART appears to be flying under the radar despite its strong fundamentals.
    Despite its impressive fundamentals, INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) remains undervalued. 
    Via Chartmill

    Performance

    YTD
    -33.66%
    -33.66%
    1 Month
    -0.62%
    -0.62%
    3 Month
    -14.99%
    -14.99%
    6 Month
    -35.35%
    -35.35%
    1 Year
    -28.90%
    -28.90%

    More News

    Read More
    CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    $1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
    Via Benzinga
    A Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 Analysts
    Via Benzinga
    Analyst Scoreboard: 5 Ratings For Integra Lifesciences
    Via Benzinga
    NASDAQ:IART is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
    Via Chartmill
    Stocks On Track For Third Green Session, Palantir Ignites Rally In Chipmakers, Commodities Rebound: What's Driving Markets Monday?
    Via Benzinga
    Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Recap: Integra Lifesciences Q4 Earnings
    Via Benzinga
    The Analyst Landscape: 7 Takes On Integra Lifesciences
    Via Benzinga
    Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday?
    Via Benzinga
    IART Stock Earnings: Integra Lifesciences Meets EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    The Latest Analyst Ratings for Integra Lifesciences
    Via Benzinga
    4 Analysts Have This to Say About Integra Lifesciences
    Via Benzinga
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART
    From Pomerantz LLP
    Via GlobeNewswire
    NASDAQ:IART is probably undervalued for the fundamentals it is displaying.
    Via Chartmill
    Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
    Via Benzinga
    NASDAQ:IART, an undervalued stock with good fundamentals.
    Via Chartmill
    INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal
    Via Benzinga
    Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    INTEGRA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.